Sign in

    Kurt Caramanidis

    Senior Research Analyst at Carl M. Hennig, Inc.

    Kurt Caramanidis is a Senior Research Analyst at Carl M. Hennig, Inc., specializing in U.S. equity research with a focus on small and mid-cap industrials, agriculture, and manufacturing firms. He has provided coverage and analysis on companies like AGCO Corporation, Oshkosh Corporation, and Manitowoc Company, building a reputation for delivering actionable insights and effective investment recommendations. Caramanidis started his financial services career in the early 2000s and joined Carl M. Hennig, Inc. in 2014, following prior roles at regional brokerages in the Midwest. He holds active FINRA Series 7 and 63 licenses and is recognized for his diligent research approach, with performance metrics placing him above peer averages for both recommendation accuracy and average return per call.

    Kurt Caramanidis's questions to S&W Seed (SANW) leadership

    Kurt Caramanidis's questions to S&W Seed (SANW) leadership • Q2 2025

    Question

    Asked about the VBO joint venture, specifically about any constraints from Shell on selling S&W's position during the strategic review and the potential for the Camelina business to ramp up next year. Also questioned if the company had considered moving to the OTC market to reduce costs.

    Answer

    The company expects the VBO/Camelina business to continue its ramp-up. Regarding the monetization of their VBO stake, they could not provide specifics but stated the board is considering all options to enhance shareholder value. They acknowledged the high cost of being a publicly traded company and confirmed that considering such efficiencies is part of the strategic review process.

    Ask Fintool Equity Research AI

    Kurt Caramanidis's questions to S&W Seed (SANW) leadership • Q2 2025

    Question

    Kurt Caramanidis inquired about potential constraints from Shell on monetizing the VBO joint venture during the strategic review, the expected ramp-up of the Camelina business, and whether the company has considered moving to the OTC market to reduce costs.

    Answer

    CEO Mark Herrmann stated he could not comment on specifics regarding the VBO stake beyond noting the board is exploring all options to enhance shareholder value. He expressed confidence in the continued ramp-up of the Camelina business. Regarding a potential move to the OTC market, Herrmann acknowledged the high costs of being a publicly traded company and confirmed that such efficiencies are being considered as part of the overall strategic review.

    Ask Fintool Equity Research AI

    Kurt Caramanidis's questions to Visionary Holdings (GV) leadership

    Kurt Caramanidis's questions to Visionary Holdings (GV) leadership • Q3 2020

    Question

    Kurt Caramanidis of Carl M. Hennig Inc. sought more specific guidance on the relationship between backlog and future revenue, asking if the historical outperformance of the 12-month backlog implies quarterly revenues should soon exceed $50 million. He also asked if the focus on smaller to medium-sized projects is expected to improve margins and requested an explanation for the lower transmission activity in the Texas Southwest region during Q3.

    Answer

    Acting Co-CEO and CFO Steve Wherry noted that while history shows revenue exceeding 12-month backlog, he would not make a specific forward-looking projection on quarterly revenue. Acting Co-CEO Jason Spivey explained that larger projects have historically yielded bigger margins, but the current competitive market has compressed them. He clarified that the Q3 Texas revenue shifted as crews were moved to Louisiana for higher-margin storm restoration work.

    Ask Fintool Equity Research AI

    Kurt Caramanidis's questions to Visionary Holdings (GV) leadership • Q1 2020

    Question

    Kurt Caramanidis from Carl M. Hennig, Inc. asked about the current bidding activity given customers are working from home, the outlook for gross margins for the remainder of 2020, and the pipeline for large project awards.

    Answer

    President and CEO John Sottile stated that while it's difficult to gauge customer productivity, he expects revenue to improve in the summer and fall. For margins, Sottile and CFO Stephen Wherry confirmed the target remains in the 16% to 19% range, noting the year-over-year improvement in Q1 to 15.3% despite MSA start-up delays. Sottile also confirmed that Goldfield is continuously bidding on large projects, though the timing of any award is uncertain.

    Ask Fintool Equity Research AI

    Kurt Caramanidis's questions to Visionary Holdings (GV) leadership • Q4 2019

    Question

    Kurt Caramanidis from Carl M. Hennig commended the company's progress and asked whether the executive bonus accrual occurs throughout the year or is a one-time event, while also acknowledging the helpful guidance on Q1 expectations.

    Answer

    Chairman, President and CEO John Sottile clarified that the bonus accrual takes place throughout the year. He also provided context on the company's cash-based compensation philosophy, where executives have historically received cash bonuses instead of stock options, and then personally purchased shares on the open market. He reiterated that this can make cash compensation appear large but is part of their overall structure.

    Ask Fintool Equity Research AI